Wire · opportunities
A Small Diagnostics Company Says It Can Predict Type 1 Diabetes Years Before Symptoms ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 August 2026 · Fusion42 review
OTraces Inc. claims its proteomic biomarker method can predict Stage 3 type 1 diabetes up to five years before symptoms with over 92% predictive power, based on retrospective analysis of TEDDY study data. However, this result is not peer-reviewed or prospectively validated and is not FDA approved yet.
This Wire brief sits within Fusion42's coverage of Diagnostics.
◆ ◆ The Wire takeaway
You now have a method claiming to spot type 1 diabetes risk years before symptoms, which could open patient recruitment and early intervention opportunities once validated. This early result invites founders in diagnostics to pursue prospective trials aggressively to lead the clinical validation race.
◆ Coverage
1 source · 13 Aug 2026
◆ Related on Wire
◆ Topics